Antonio F. Cruz

Antonio F.
Cruz was the founder of Angiotech Pharmaceuticals, Inc. (founded in 1992) where he held the title of Director & Vice President.
He is also the founder of Transition Therapeutics, Inc. (founded in 1998) where he serves as the Chief Executive Officer.
Dr. Cruz currently holds the position of Chairman & Chief Executive Officer at NeuroMedix, Inc. He is also a Director at Treat U SA, Accel-Rx, and Mercal Capital Corp.
(since 2015).
Dr. Cruz has previously served as the President & Chief Executive Officer of the Canadian Arthritis Network.
He has also been a Director at Ellipsis Neurotherapeutics, Inc., BIOTECanada, and Mount Sinai Hospital (Canada) where he held the title of Senior Scientist.